Holdings
Ra Capital Management, L.P.
As of Jun 30, 2026, Ra Capital Management, L.P. reported 79 positions worth US$8.07B. Largest: Parabilis Medicines, Inc., Rhythm Pharmaceuticals, Inc. and Vaxcyte, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Parabilis Medicines, Inc. | 28.9M | US$792M | new | Jun 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 6.67M | US$740M | no change | Jun 30, 2026 |
| Vaxcyte, Inc. | 11.5M | US$667M | no change | Jun 30, 2026 |
| Sionna Therapeutics, Inc. | 9.91M | US$436M | no change | Jun 30, 2026 |
| Tyra Biosciences, Inc. | 12.2M | US$390M | no change | Jun 30, 2026 |
| Edgewise Therapeutics, Inc. | 8.39M | US$341M | −2.04M | Jun 30, 2026 |
| Hemab Therapeutics Holdings, Inc. | 7.81M | US$287M | new | Jun 30, 2026 |
| Septerna, Inc. | 7M | US$234M | no change | Jun 30, 2026 |
| Bicara Therapeutics Inc. | 7.26M | US$215M | no change | Jun 30, 2026 |
| Mineralys Therapeutics, Inc. | 7.69M | US$208M | no change | Jun 30, 2026 |